Descriptive statistics, eyes with secondary glaucoma
| Gender | Age at surgery | Age at research examination | Aetiology | Prematurity | Morphology | Age at glaucoma diagnosis | Treatment | CDVA logMAR | VAO surgery (n) | |
| 1-OD | F | I | MC | No | Lamellar and nuclear | EC | Ahmed valve | 0.56 | 3 | |
| 1-OS | F | I | MC | No | Lamellar and nuclear | EC | Trabeculectomia | 0.62 | 2 | |
| 2-OS | M | I | MC | Down syndrome | Yes | Lamellar | EC | Drops only | Not achievable | 1 |
| 3-OD | M | I | MC | No | Nuclear | MC | Drops only | 0.3 | 5 | |
| 3-OS | M | I | MC | No | Nuclear | MC | Drops only | 0.28 | 5 |
CDVA, corrected distance visual acuity; EC, early childhood (2–5 years); F, female; I, infancy (28 days–12 months); M, male; MC, middle childhood (6–11 years); no, number; OD, right eye; OS, left eye; Pt, patient; VAO, visual axis opacification.